Most Popular Brands: Ditropan, Ditropan XL, Oxytrol (Show all)
Oxybutynin is anti-cholinergic drug used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination (urge incontinence), by decreasing muscle spasms of the bladder. It is available in oral form, extended release and as a transdermal patch.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Bladder problems | 185 |
|
|
|
|
|
30 |
| Urinary urgency | 35 |
|
|
6 | |||
| Other | 24 |
|
|
|
3 | ||
| Incontinence | 17 |
|
|
|
3 | ||
| Urinary frequency | 13 |
|
1 | ||||
| General health | 10 | 0 |
See all 295 patients currently taking Oxybutynin
Mouse over the table for more information
Top 10 dosages based on patients currently taking Oxybutynin. See all 34 dosages ►
| 10mg as needed | 35g as needed | 3 5mg as needed | 5mg/5mL as needed | 5 mg all the time (24/7) | 5mg as needed | 6 x 5 mg/5 mL all the time (24/7) | 8mg as needed | as needed | daily | 2 x 3.9 mg/24 hr weekly | 2 mg daily | 2 tps. daily | 2.5 mg daily | 3.5 mg daily | 3.9 mg/24 hr daily | 3.9 mg daily | 5 mg/5 mL daily | 5 mg daily | 7.5 mg daily | 2 x 3.9 mg/24 hr daily | 10 mg daily | 2 x 5 mg/5 mL daily | 15 mg daily | 15 tbs. daily | 3 x 5 mg/5 mL daily | 20 mg daily | 4 x 5 mg/5 mL daily | 25 mg daily | 30 mg daily | 40 mg daily | 45 mg daily | 225 mg daily | 500 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2
|
1
|
1
|
1
|
1
|
7
|
1
|
1
|
2
|
17
|
1
|
1
|
1
|
2
|
1
|
10
|
3
|
11
|
58
|
2
|
4
|
102
|
2
|
34
|
1
|
2
|
18
|
1
|
1
|
3
|
2
|
1
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Doctor's advice
|
24 | 33% |
|
|
Other
|
22 | 30% |
|
|
Did not seem to work
|
18 | 25% |
|
|
Side effects too severe
|
10 | 14% |
|
|
Course of treatment ended
|
5 | 7% |
|
|
Expense
|
4 | 5% |
|
|
Not indicated
|
3 | 4% |
|
|
Personal research
|
2 | 3% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.